Apellis Pharmaceuticals, Inc. · NASDAQ:APLS

BIOGEN INC. reported a 14.20% stake in Apellis Pharmaceuticals, Inc. (Schedule 13D)

Event Mar 31, 2026 · Filed Apr 6, 2026

BIOGEN INC. reported a 14.20% stake in Apellis Pharmaceuticals, Inc., 18,469,475 shares, with active intent on Mar 31, 2026. Filed Apr 6, 2026 (Schedule 13D).

Stake
14.20%
Shares
18,469,475
Intent
Active
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BIOGEN INC.14.20%18,469,475

Source

View original at SEC

Related